Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 Mar;55(3):190–192. doi: 10.1136/ard.55.3.190

Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study.

A E Voskuyl 1, A H Zwinderman 1, M L Westedt 1, J P Vandenbroucke 1, F C Breedveld 1, J M Hazes 1
PMCID: PMC1010127  PMID: 8712883

Abstract

OBJECTIVE: To investigate those characteristics of patients with rheumatoid arthritis (RA) that are associated with the development of rheumatoid vasculitis (RV). METHODS: Demographic and clinical data of 69 patients who had been diagnosed as having RV were compared with those of 138 contemporaneous control patients with RA who were not suspected to have vasculitis. Vasculitis was confirmed histologically in 96% of the subjects with RV. RESULTS: Variables associated with the development of RV were: 1) male gender, presence of increased serum concentrations of rheumatoid factor, joint erosions, subcutaneous nodules, number of disease modifying antirheumatic drugs previously prescribed, treatment (ever) with D-penicillamine or azathioprine; 2) presence of nail fold lesions and any other extrarticular feature one year before the time of diagnosis of RV; 3) treatment with corticosteroids at the time of diagnosis of RV. CONCLUSIONS: The development of RV is associated with male gender, extra-articular features, and a severe course of RA as indicated by the presence of joint destruction and need for intensive treatment with antirheumatic drugs. The strongest association was found with the presence of increased concentrations of rheumatoid factor.

Full text

PDF
192

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BYWATERS E. G., SCOTT J. T. THE NATURAL HISTORY OF VASCULAR LESIONS IN RHEUMATOID ARTHRITIS. J Chronic Dis. 1963 Aug;16:905–914. doi: 10.1016/0021-9681(63)90139-5. [DOI] [PubMed] [Google Scholar]
  2. Lie J. T. Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis. Arthritis Rheum. 1990 Aug;33(8):1074–1087. doi: 10.1002/art.1780330804. [DOI] [PubMed] [Google Scholar]
  3. Pope R. M., Yoshinoya S., McDuffy S. J. Detection of immune complexes and their relationship to rheumatoid factor in a variety of autoimmune disorders. Clin Exp Immunol. 1981 Nov;46(2):259–267. [PMC free article] [PubMed] [Google Scholar]
  4. Scott D. G., Bacon P. A., Tribe C. R. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 1981 Jul;60(4):288–297. [PubMed] [Google Scholar]
  5. Struthers G. R., Scott D. L., Delamere J. P., Sheppeard H., Kitt M. Smoking and rheumatoid vasculitis. Rheumatol Int. 1981;1(3):145–146. doi: 10.1007/BF00541260. [DOI] [PubMed] [Google Scholar]
  6. Theofilopoulos A. N., Burtonboy G., LoSpalluto J. J., Ziff M. IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis. Arthritis Rheum. 1974 May-Jun;17(3):272–284. doi: 10.1002/art.1780170312. [DOI] [PubMed] [Google Scholar]
  7. Vollertsen R. S., Conn D. L., Ballard D. J., Ilstrup D. M., Kazmar R. E., Silverfield J. C. Rheumatoid vasculitis: survival and associated risk factors. Medicine (Baltimore) 1986 Nov;65(6):365–375. [PubMed] [Google Scholar]
  8. Watts R. A., Carruthers D. M., Symmons D. P., Scott D. G. The incidence of rheumatoid vasculitis in the Norwich Health Authority. Br J Rheumatol. 1994 Sep;33(9):832–833. doi: 10.1093/rheumatology/33.9.832. [DOI] [PubMed] [Google Scholar]
  9. Westedt M. L., Breedveld F. C., Schreuder G. M., D'Amaro J., Cats A., de Vries R. R. Immunogenetic heterogeneity of rheumatoid arthritis. Ann Rheum Dis. 1986 Jul;45(7):534–538. doi: 10.1136/ard.45.7.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Westedt M. L., Meijer C. J., Vermeer B. J., Cats A., de Vries E. Rheumatoid arthritis--the clinical significance of histo- and immunopathological abnormalities in normal skin. J Rheumatol. 1984 Aug;11(4):448–453. [PubMed] [Google Scholar]
  11. Wilkinson M., Torrance W. N. Clinical background of rheumatoid vascular disease. Ann Rheum Dis. 1967 Nov;26(6):475–480. doi: 10.1136/ard.26.6.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. van Zeben D., Hazes J. M., Zwinderman A. H., Vandenbroucke J. P., Breedveld F. C. Factors predicting outcome of rheumatoid arthritis: results of a followup study. J Rheumatol. 1993 Aug;20(8):1288–1296. [PubMed] [Google Scholar]
  13. van der Heijde D. M., van Riel P. L., van Leeuwen M. A., van 't Hof M. A., van Rijswijk M. H., van de Putte L. B. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol. 1992 Aug;31(8):519–525. doi: 10.1093/rheumatology/31.8.519. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES